drugdiscovery.pharmaceutical-business-review.comDrug Discovery Archives - Pharmaceutical Business review

Pharmaceutical Business review Pharmaceutical Business review is using cookies Continue Learn More Close ☰ Search × HomeAdd Company Advertise with us Contact us Events Suplpiers News Clinical Trials Drug Discovery Packaging & Supply Chain Production & Sales Regulation Advertise With Us Advertise on our extensive network of industry websites and newsletters. Get the PBR newsletter Sign up to our free email to get all the latest PBR news. Home Drug Discovery Drug Discovery Research & Development Pre-clinical Studies Research & Development PharmaLogic launches new radiopharmaceutical facility in New York, US Research & Development Manufacturing Latus Bio secures $54m for CNS gene therapy development Research & Development Clinical Trials Clinical Trials Patient Enrollment Human Trials Patient Enrollment US FDA approves Avacta Group’s IND application for AVA6000 Clinical Trials Patient Enrollment AM-Pharma enrols first patients in Covid-19 phase III trial Clinical Trials Patient Enrollment Regulation Regulation Drug Filing Approvals Rejections Marketing Authorisation Patents Lawsuits Drug Filing FDA accepts BLA for BMS’ subcutaneous nivolumab to treat solid tumours Drug Filing Oncology USFDA accepts NextPoint Therapeutics’s IND for NPX887 Drug Filing Production & Sales Production & Sales Manufacturing Launches Recalls Marketing & Sales Manufacturing PharmaLogic launches new radiopharmaceutical facility in New York, US Research & Development Manufacturing IMA Life to build new pharma freeze-drying equipment production site Manufacturing Pharmaceuticals and Healthcare Packaging & Supply Chain Packaging & Supply Chain Packaging Cold Chain Distribution Storage Packaging Gerresheimer Packaging PCI Pharma announces bottling line expansion at Rockford site Packaging & Supply Chain Packaging Suppliers Suppliers A-Z Suppliers Products & Services Videos White Papers No data found EventsRegister Log In Drug Discovery 14 May 2024 Research & Development Manufacturing PharmaLogic launches new radiopharmaceutical facility in New York, US By PBR Staff Writer PharmaLogic, a contract development and manufacturing organization (CDMO) and provider of radiopharmacy solutions, has announced the launch of its new radiopharmaceutical manufacturing and research facility at the Bronx in New York city, US. 10 May 2024 Drug Discovery Clinical Trials Metabolic Disorders Aardvark Therapeutics secures $85m in Series C funding round By PBR Staff Writer Aardvark Therapeutics has secured $85m in an oversubscribed Series C financing round, with Decheng Capital spearheading the investment, to complete studies of ARD-101. 07 May 2024 Oncology Drug Discovery OverT Bio secures $16m in seed funding for cell therapy development By PBR Staff Writer Data-driven biotechnology company OverT Bio has secured $16m in a seed funding round to expand its discovery platforms aimed at developing cellular therapies for solid tumours. 03 May 2024 Research & Development Latus Bio secures $54m for CNS gene therapy development By PBR Staff Writer Latus Bio, a biotechnology company specialising in new gene therapy candidates for central nervous system (CNS) disorders, has announced its launch alongside an initial $54m Series A financing. 01 May 2024 Research & Development Scenic Biotech, Bristol Myers Squibb to develop new drug targets By PBR Staff Writer Scenic Biotech has entered into a new research partnership with Bristol Myers Squibb, aimed at accelerating the development of new drug targets. 30 Apr 2024 Research & Development Approvals Genmab and Pfizer’s TIVDAK sBLA secures full FDA approval By PBR Staff Writer Genmab and Pfizer have announced that the US Food and Drug Administration (FDA) granted full approval to TIVDAK’s (tisotumab vedotin-tftv) supplemental Biologics License Application (sBLA) to treat patients with recurrent or metastatic cervical cancer who have experienced disease progression on or after chemotherapy. 29 Apr 2024 Research & Development Approvals FDA approves Ractigen Therapeutics’ RAG-01 IND for bladder cancer By PBR Staff Writer Ractigen Therapeutics has received approval from the US Food and Drug Administration (FDA) for its Investigational New Drug (IND) application for saRNA therapy RAG-01. 19 Apr 2024 Research & Development Oncology SK pharmteco signs agreement to manufacture Ferring’s ADSTILADRIN By PBR Staff Writer Ferring Pharmaceuticals and SK pharmteco have entered into an agreement to increase commercial manufacturing capacity for Ferring’s ADSTILADRIN (nadofaragene firadenovec-vncg), ensuring a long-term supply of the non-replicating adenoviral vector-based gene therapy. 16 Apr 2024 Research & Development Approvals Telix Pharmaceuticals secures FDA fast track status for TLX101-CDx By PBR Staff Writer Telix Pharmaceuticals has received fast track designation from the US Food and Drug Administration (FDA) for its investigational glioma imaging product, TLX101-CDx (Pixclara). 15 Apr 2024 Research & Development Biotechnology Immuno-oncology company Portage Biotech to evaluate strategic alternatives By PBR Staff Writer Clinical-stage immuno-oncology company Portage Biotech has announced plans to expand its assessment of strategic alternatives.Advertise with us Contact us PRIVACY POLICY TERMS AND CONDITIONS © PBR 2024. Part of Progressive Trade Media Ltd. Lost Password Back ⟶ Login Register Get new password Lost Password? Login Registration is...